Pharmaceutical patents : incentives for R&D or marketing?
Working paper
Permanent lenke
http://hdl.handle.net/11250/162674Utgivelsesdato
2005-11Metadata
Vis full innførselSamlinger
- Discussion papers (SAM) [649]
Sammendrag
We analyse how a patent-holding pharmaceutical firm may strategically use advertising
of existing drugs to affect R&D investments in new (differentiated) drugs, and
thereby affect the probability distribution of future market structures in the industry.
Within a fairly general model framework, we derive exact conditions for advertising
and R&D being substitute strategies for the incumbent firm and show that it may
overinvest in advertising to reduce the incentive for an entrant to invest in R&D,
thereby reducing the probability of a new product on the market. In a more specific
setting of informative advertising, we show that such overinvestment incentives are
always present, and that more generous patent protection implies that a larger share
of the patent rent is spent on marketing, relative to R&D.
Utgiver
Norwegian School of Economics and Business Administration. Department of EconomicsSerie
Discussion paper2005:22